posttransl
modif
ptm
protein
crucial
finetun
cell
respons
intracellular
extracellular
cue
adpribosyl
ptm
occur
two
flavour
modif
target
multipl
adpribos
moieti
poli
adpribosyl
ation
paryl
one
unit
maryl
ad
differ
enzym
parp
famili
also
known
artd
famili
paryl
rel
wellstudi
particularli
dna
damag
respons
result
develop
parp
inhibitor
olaparib
increasingli
employ
cancer
chemotherapeut
approach
despit
fact
major
parp
enzym
catalys
maryl
maryl
well
understood
paryl
maryl
dynam
process
enzym
revers
intracellular
maryl
acid
amino
acid
discov
sinc
howev
littl
inform
publish
physiolog
function
macrodomain
harbour
catalyt
site
domain
identifi
despit
lack
inform
regard
cellular
role
number
studi
link
cancer
howev
public
oppos
reli
poorlycharacteris
antibodi
aberr
localis
overexpress
rather
nativ
protein
review
critic
assess
avail
literatur
role
hydrolas
cancer
find
current
limit
evid
role
tumorigenesi
cancer
enzym
capabl
paryl
moreov
protein
also
dna
identifi
target
adpribosyl
catalys
follow
also
describ
potenti
therapeut
target
certain
cancer
recent
addit
spectrum
adpribosyl
molecul
rna
modifi
vitro
multipl
parp
one
beststudi
still
bare
understood
maryl
enzym
initi
identifi
interactor
myc
later
ubiquitin
prolifer
cell
nuclear
antigen
pcna
overexpress
lead
cell
death
hela
cell
unknown
mechan
contrast
nontransform
cell
overexpress
lead
stimul
cell
growth
given
role
replic
dna
damag
well
mitochondri
metabol
clear
relev
substrat
enzym
potenti
substrat
identifi
use
protein
microarray
perform
paryl
howev
partial
due
lack
antibodi
time
modif
verifi
occur
cell
also
report
regul
nfkb
signal
function
coactiv
describ
anticanc
antiinflammatori
target
review
detail
elsewher
locat
endoplasm
reticulum
er
play
role
unfold
protein
respons
recent
function
identifi
maryl
role
antivir
defenc
gene
express
induc
adpribosyl
mediat
parp
may
function
counteract
viral
prolifer
addit
enzym
parp
famili
sever
sirtuin
sirt
appear
abl
adpribosyl
substrat
addit
betterstudi
nad
depend
deacylas
activ
first
research
show
sirt
possess
maryl
activ
describ
weak
activ
paper
focus
singl
enzym
show
mitochondri
maryl
glutam
dehydrogenas
downregul
insulin
secret
nuclear
modifi
regul
activ
lastli
nucleolar
report
maryl
histon
date
littl
inform
avail
maryl
activ
sirt
function
consequ
maryl
normal
cell
physiolog
thu
appear
divers
review
extens
elsewher
herein
focu
enzym
revers
intracellular
maryl
reaction
macrodomaincontain
hydrolas
intim
link
adpribosyl
protein
structur
modul
known
macrodomain
name
unusu
larg
histon
identifi
macrodomain
protein
fold
form
around
central
flank
form
pocket
adpribos
bind
pocket
slightli
differ
macrodomaincontain
protein
consequ
macrodomaincontain
protein
famili
subdivid
macrodomain
bind
par
other
bind
mar
macrodomain
serv
bind
modul
mediat
protein
interact
depend
adpribosyl
number
catalyt
activ
poli
adpribosyl
glycohydrolas
parg
abl
degrad
par
chain
cleav
glycosid
bond
adjac
adpribos
moieti
howev
remov
final
adpribos
attach
protein
three
protein
activ
toward
par
capabl
remov
adpribos
moieti
connect
protein
partner
presum
cleav
ester
bond
adpribos
acid
receptor
amino
acid
therefor
revers
maryl
gener
parp
enzym
also
remov
last
adpribos
left
behind
parg
human
macrodomaincontain
protein
known
today
protein
identifi
sequenc
homolog
macrodomain
parg
recognis
structur
solv
indic
possibl
macrodomaincontain
protein
remain
identifi
recent
bioinformat
approach
suggest
larg
uncharacteris
protein
predict
molecular
weight
kda
howev
due
cleavag
nterminu
upon
transloc
mitochondria
protein
detect
western
blot
wb
smaller
posttransl
modif
protein
myriad
consequ
chang
interactom
stabil
localis
activ
exampl
date
type
modif
known
addit
adpribos
moieti
protein
first
report
chain
poli
adpribos
par
identifi
target
protein
term
poli
adpribosyl
ation
paryl
sinc
paryl
intens
studi
lead
identif
crucial
role
repair
dna
damag
develop
specif
inhibitor
utilis
clinic
treat
divers
cancer
contrast
much
less
known
smaller
sibl
mono
adpribosyl
ation
maryl
singl
adpribos
unit
mar
conjug
protein
first
note
maryl
rather
paryl
activ
late
becom
clear
minor
parp
harbour
macrodomain
least
macrolik
domain
remain
confirm
experiment
macrodomain
evolutionari
wellconserv
modul
instanc
recent
work
shown
certain
alphavirus
encod
protein
macrodomainlik
fold
display
catalyt
activ
toward
maryl
protein
exist
protein
enhanc
evid
connect
exist
link
maryl
immun
review
focu
specif
potenti
oncogen
function
mono
adpribosyl
hydrolas
also
note
howev
macrodomaincontain
protein
parg
previous
link
close
cancer
rel
small
protein
tabl
without
notabl
domain
besid
macrodomain
first
catalyt
activ
recognis
deacetyl
oacetyladpribos
oaadpr
gener
acetyl
adpribos
oaadpr
aris
byproduct
sirtmedi
deacetyl
acetyl
group
transfer
onto
adpribos
releas
nicotinamid
may
import
biolog
function
two
year
later
three
lab
report
activ
remov
adpribos
protein
substrat
propos
limit
remov
adpribos
acid
amino
acid
serin
arginin
maryl
suggest
remov
respect
structur
differ
protein
contain
macrodomain
report
capabl
remov
adpribos
modifi
singlestrand
dna
also
capabl
remov
adpribos
maryl
singlestrand
rna
lastli
hydrolysi
ad
list
vitro
activ
date
known
activ
relev
function
cell
either
normal
physiolog
patholog
condit
predominantli
due
fact
well
known
preval
vitro
substrat
cell
cellular
function
may
partial
due
fact
antibodi
modul
recognis
maryl
develop
recent
technic
develop
possibl
confirm
antibodi
maryl
protein
take
place
cell
henc
revers
mediat
macrodomaincontain
protein
could
also
assess
current
still
straightforward
estim
endogen
maryl
level
cell
inhibitor
avail
experiment
procedur
cell
fixat
lysi
maryl
could
possibl
remov
enzym
therefor
go
undetect
one
studi
perform
identifi
inhibitor
use
alphascreen
assay
inhibitor
micromolar
rang
identifi
serv
lead
compound
optimis
like
specif
enough
yet
use
studi
cell
due
activ
concentr
anoth
studi
identifi
alloster
inhibitor
macrodomain
block
bind
adpribos
howev
test
whether
identifi
compound
might
inhibit
one
macrodomain
catalyt
activ
ubiquit
express
leav
nucleoli
upon
dna
damag
role
normal
cell
biolog
process
well
understood
appear
express
localis
differ
tissu
intracellular
locat
clearli
give
uniqu
role
play
despit
biochem
similar
also
explain
loss
alon
lead
neurodegen
phenotyp
resid
mitochondria
depend
tag
use
overexpress
resid
exclus
nucleu
instead
display
diffus
cytoplasmicnuclear
distribut
overexpress
appear
present
nucleoplasm
nucleoli
cytoplasm
stress
granul
express
throughout
differ
tissu
enrich
skelet
muscl
protein
rna
level
thu
far
detect
human
neuroblastoma
cell
mous
cortic
neuron
sever
report
correl
polymorph
delet
within
gene
autismspectrum
disord
clear
howev
whether
gene
product
surround
gene
respons
associ
even
though
elev
protein
express
neuron
support
potenti
brainspecif
function
howev
long
noncod
rna
identifi
within
intron
gene
highli
express
tissu
investig
mrna
therebi
potenti
confus
correl
mutat
gene
phenotyp
anoth
genomewid
associ
studi
identifi
factor
influenc
vascularadhes
level
author
confirm
knockdown
lead
lower
express
adipocyt
presum
transcript
regul
also
report
leav
nucleu
upon
dna
damag
depend
phosphoryl
atm
wherea
localis
nucleoli
nuclear
site
damag
unclear
function
relev
data
may
found
also
known
leukaemiarel
protein
attribut
number
function
nucleu
coactiv
androgen
receptor
counteract
maryl
nucleu
activ
nfkb
signal
also
report
enhanc
oestrogen
receptor
signal
upregul
stimul
cell
oestrogen
regulatori
factor
identifi
yet
bioid
interact
screen
identifi
protein
close
proxim
protein
interest
identifi
mani
protein
involv
nuclearcytoplasm
mitochondri
nucleic
acid
metabol
interactor
respect
whether
protein
maryl
serv
substrat
remain
determin
possibl
despit
spatiotempor
restrict
respect
compart
involv
similar
signal
network
converg
regul
cellular
nucleic
acid
physiolog
function
three
enzym
remain
elus
puzzl
perhap
moment
despit
mitochondri
localis
major
report
describ
nuclear
function
futur
work
need
address
appar
discrep
posttransl
modif
poli
adpribosyl
ation
intim
link
cancer
posttransl
modif
phosphoryl
patient
inhibitor
shown
effect
specif
tumour
cell
appli
clinic
howev
one
rare
exampl
synthet
lethal
interact
better
understand
process
regul
maryl
provid
opportun
drug
develop
exemplifi
current
research
potenti
drug
target
littl
known
potenti
role
mono
adpribosyl
hydrolas
cancer
exhibit
mutat
cancer
patient
sampl
respect
sampl
cbioport
curat
dataset
fact
mutat
rate
twice
rate
seen
like
reflect
gene
larger
figur
locat
known
fragil
region
specif
recur
delet
exon
observ
esophag
squamou
cell
carcinoma
gastric
cancer
fusion
identifi
leukaemia
fusion
pleomorph
sarcoma
despit
low
number
identifi
mutat
patient
tumour
sampl
sever
report
correl
express
level
clinic
outcom
describ
next
paragraph
gene
structur
shown
schemat
lncrna
present
howev
display
sinc
shown
relev
cd
code
sequenc
utr
untransl
region
number
studi
address
potenti
oncogen
function
start
deciph
molecular
mechan
underli
observ
effect
express
shown
upregul
oestrogen
lead
sever
studi
role
tumour
differenti
oestrogen
statu
overexpress
oestrogen
progesteron
receptor
posit
ishikawa
cell
deriv
endometri
cancer
effect
cell
prolifer
howev
enhanc
invas
cell
measur
transwel
assay
mechanist
author
propos
mechan
wherein
depend
oestrogen
block
recruit
ecadherin
promot
lower
ecadherin
express
enhanc
invas
shrnamedi
knockdown
achiev
opposit
effect
enhanc
ecadherin
express
impli
import
factor
metastasi
find
appear
contradict
earlier
report
overexpress
cell
oestrogenrespons
breast
cancer
cell
show
effect
cell
growth
led
enhanc
prolifer
later
report
studi
cell
show
knockdown
sensit
cell
apoptosi
studi
thu
clear
effect
loss
gain
cell
physiolog
recent
work
demonstr
fuse
ntermin
tag
gfp
lead
nuclear
localis
wherea
ctermin
label
endogen
protein
appear
exclus
localis
mitochondria
mass
spectrometri
dataset
also
detect
mitochondria
exclud
possibl
specif
circumst
may
relocalis
nucleu
pathogen
condit
presenc
fusion
protein
identifi
leukaemia
protein
like
also
localis
nucleu
instead
mitochondria
runx
fusion
mask
mitochondri
target
sequenc
compar
localis
label
ntermin
gfp
tag
unfortun
studi
investig
either
use
ntermin
tag
fusion
construct
state
clearli
fusion
protein
gener
furthermor
major
appli
antibodi
show
multipl
band
western
blot
henc
suitabl
immunohistochemistri
ihc
immunofluoresc
tabl
worthwhil
repeat
studi
molecular
function
carcinogenesi
clarifi
whether
unlabel
overexpress
lead
enhanc
cell
growth
whether
effect
depend
tumour
background
also
studi
knockdownknockout
system
thoroughli
despit
technic
challeng
multipl
studi
correl
tumour
growth
express
either
xenograft
model
patient
cohort
overexpress
hepatocellular
carcinoma
line
lead
decreas
cell
growth
metastat
potenti
measur
transwel
assay
furthermor
deliv
nude
mice
cell
overexpress
lead
decreas
tumour
volum
lower
metastat
potenti
compar
cell
without
overexpress
inform
avail
distinguish
whether
genuin
effect
artefact
due
forc
nuclear
localis
overexpress
construct
similar
set
experi
pancreat
carcinoma
cell
line
opposit
result
achiev
knockdown
lead
enhanc
apoptosi
decreas
cell
growth
howev
one
shrna
construct
use
effect
seen
could
potenti
offtarget
cell
overexpress
construct
studi
describ
grew
faster
resist
apoptosi
xenograft
experi
show
trend
cell
lack
lower
tumourform
potenti
higher
surviv
rate
cell
overexpress
higher
tumour
volum
lower
surviv
rate
author
comment
oppos
effect
two
tumour
type
agre
largerscal
studi
requir
verifi
find
third
studi
show
ihc
lung
tumour
sampl
antibodi
unknown
sourc
specif
high
express
measur
ihc
report
correl
neg
outcom
colorect
carcinoma
gastric
carcinoma
howev
antibodi
use
gener
author
valid
western
blot
crisprmedi
knockout
rhabdomyosarcoma
cell
knockout
mice
appear
viabl
make
unlik
loss
drastic
growth
inhibitori
development
effect
conclus
data
avail
oncogen
function
reli
poorli
characteris
antibodi
unclear
overexpress
construct
singl
shrna
construct
major
studi
would
need
reproduc
thorough
characteris
descript
materi
use
abl
draw
deeper
conclus
sever
studi
agre
express
induc
oestrogen
remain
unclear
effect
overexpress
cell
fusion
identifi
leukaemia
may
provid
import
hint
potenti
patholog
function
possibl
physiolog
mitochondri
localis
turn
pathogen
nuclear
one
aberrantli
act
transcript
activ
interest
see
whether
instanc
identifi
fusion
present
altern
mask
event
may
occur
cell
bind
interact
partner
ptm
therebi
redirect
protein
nucleu
physiolog
function
number
analys
suggest
may
play
potenti
role
cancer
copi
number
increas
three
differ
tamoxifenresist
breast
cancer
cell
line
prompt
author
analys
express
patient
sampl
oestrogen
receptorposit
tissu
breast
cancer
patient
record
tamoxifenresist
howev
three
patient
display
decreas
copi
number
wherea
two
patient
show
increas
use
ihc
custom
antibodi
vari
level
detect
primari
secondari
tumour
tissu
patient
collect
show
may
overexpress
cancer
tissu
cell
exogen
overexpress
grow
faster
control
cell
media
contain
tamoxifen
impli
confer
tamoxifenresist
cell
appear
stimul
tamoxifen
demonstr
faster
growth
medium
tamoxifen
without
convers
tamoxifenresist
clone
shrnamedi
knockdown
becom
sensit
even
though
complet
revers
resist
may
mediat
activ
oestrogenregul
gene
respons
tamoxifen
cell
overexpress
lastli
cell
stabli
express
shrna
knockdown
grow
markedli
slower
nude
mice
author
argu
cancer
specif
fragil
site
gene
lost
fragil
also
allow
amplif
specif
case
erposit
breast
cancer
treat
tamoxifen
incur
resist
recent
studi
show
approxim
onethird
colorect
carcinoma
investig
heterozyg
homozyg
loss
map
within
gene
major
intragen
microdelet
map
region
exon
test
whether
defici
promot
tumourigenesi
knockout
introduc
adenomat
polyposi
coli
protein
apc
mous
model
mutat
apc
tumour
suppressor
major
driver
sporad
colorect
cancer
could
shown
even
haploinsuffici
lead
larger
adenoma
format
furthermor
human
cell
transplant
nude
mice
display
increas
tumour
growth
lack
reduc
tumour
growth
overexpress
underli
mechan
suggest
impair
activ
cell
lead
increas
sensit
dna
damag
ultim
caus
enhanc
chromosom
instabl
find
appear
paradox
previou
report
loss
impair
cell
growth
loss
resist
tamoxifen
knockout
mice
show
alter
surviv
rate
subleth
irradi
compar
wildtyp
mice
indic
loss
alon
suffici
drive
tumourigenesi
trigger
dna
damag
clear
whether
loss
overexpress
contribut
tumourigenesi
whether
drive
tumour
growth
depend
condit
function
dna
damag
repair
system
oestrogen
receptor
statu
investig
stageiii
colon
cancer
express
determin
immunohistochemistri
found
correl
poor
surviv
human
protein
atla
antibodi
use
work
retract
compani
meantim
appear
valid
way
western
blot
sirnamedi
knockdown
thu
clear
whether
antibodi
recognis
whether
recognis
addit
protein
may
upregul
sampl
analys
altogeth
appear
loss
suffici
drive
tumourigenesi
may
addit
effect
model
prone
tumour
format
loss
apc
colorect
cell
studi
urgent
need
clarifi
exact
role
onset
cancer
well
respons
exist
tumour
therapi
phenotyp
associ
express
neurodegener
occur
due
mutat
lead
truncat
protein
disrupt
macrodomain
therebi
loss
catalyt
activ
clear
whether
neurodegener
result
potenti
toxic
truncat
unfold
protein
loss
hydrolas
activ
knockdown
lead
decreas
cell
prolifer
slight
increas
senesc
cell
deriv
osteosarcoma
crisprmedi
knockdown
influenc
hela
prolifer
leav
unclear
set
requir
cell
growth
overexpress
lead
chang
cell
prolifer
could
identifi
data
link
cancer
see
elev
express
mutat
databas
cosmic
base
express
level
databas
experiment
result
stage
appear
unlik
involv
cancer
even
though
experiment
requir
despit
presenc
sever
public
report
correl
level
cancer
develop
progress
clear
moment
caus
role
potenti
relev
erposit
tamoxifen
resist
breast
cancer
may
confer
resist
treatment
howev
larger
cohort
patient
sampl
need
analys
substanti
initi
find
loss
apc
null
background
potenti
stimul
tumour
format
howev
loss
alon
effect
knockout
mous
model
detail
studi
requir
determin
loss
might
cooper
loss
apc
drive
cancer
level
upregul
oestrogen
unclear
consequ
cell
yet
may
downregul
ecadherin
therebi
promot
metastasi
confirm
may
attract
therapeut
target
intend
keep
cancer
dormant
prevent
metastasi
conflict
data
show
overexpress
knockdown
effect
stimulu
inhibit
cell
growth
impli
perhap
inhibit
may
detriment
effect
whole
organ
rather
may
depend
tumour
background
thu
may
repres
valid
drug
target
effect
observ
may
howev
depend
construct
use
well
specif
celltyp
studi
detail
futur
work
dissect
context
loss
gain
may
drive
aspect
cancer
growth
recent
develop
characteris
specif
antibodi
ongo
improv
mass
spectrometr
measur
maryl
also
attempt
make
specif
inhibitor
transferas
hydrolas
allow
detail
analysi
patho
physiolog
function
near
futur
partial
paradox
find
describ
undoubtedli
clarifi
better
valid
tool
determin
extent
relev
tumourigenesi
order
establish
potenti
drug
candid
author
declar
conflict
interest
